Technological evolution of diagnostic testing in oncology

Personalized Medicine
Julius Alexander Steffen, Christian Lenz

Abstract

Diagnostic testing has been improving the quality of cancer care. The dynamics of this field can be grasped through the application of innovation lifecycle models. Single testing, parallel testing and whole-genome sequencing are major technological evolutions. Given the increasing availability of biomarkers, the performance of single testing will be limited in the future, favoring the further implementation of parallel testing technologies. Whole-genome sequencing will lead to a further performance increase by introducing the era of genomic medicine. A broad adoption of presently available diagnostic technologies sets up the infrastructure for future technologies. The speed at which these technologies are introduced depends heavily on the regulatory and reimbursement environment, while their final diffusion is subject to pragmatic criteria such as user friendliness, perceived risk and perceived value added.

References

Mar 16, 2006·Pharmacogenetics and Genomics·Shuen-Iu HungYuan-Tsong Chen
Apr 24, 2007·The Journal of Experimental Biology·Neil Hall
Oct 11, 2008·Nature Biotechnology·Avak KahvejianJohn F Thompson
Mar 21, 2009·Nature Reviews. Drug Discovery·Jerel C DavisPhilip Ma
Aug 12, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leora Horn, William Pao
Feb 18, 2010·Personalized Medicine·Matthew J WalterTimothy J Ley
Oct 12, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Fred R HirschPaul A Bunn
Jan 21, 2011·The New England Journal of Medicine·Jim McDermott
Apr 6, 2011·Expert Review of Molecular Diagnostics·Zhenqiang SuLeming Shi
May 7, 2011·Expert Review of Molecular Diagnostics·Jeffrey N Gibbs
Nov 11, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L V SequistD Dias-Santagata
Dec 6, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Erik ThunnissenFlorian Laenger
Dec 7, 2011·Virchows Archiv : an International Journal of Pathology·H MochT D Szucs
Dec 20, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Nichole T TannerGerard A Silvestri
Jan 25, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ben TranLillian L Siu
Apr 18, 2012·Current Medicinal Chemistry·M Ilie, P Hofman
Aug 28, 2012·Science·Gopa IyerDavid B Solit
May 1, 2012·Personalized Medicine·Jeffrey E Saffitz
May 1, 2012·Personalized Medicine·Richard L HaspelV O Speights
May 1, 2012·Personalized Medicine·David Korn
May 1, 2012·Personalized Medicine·James M Crawford, Mara G Aspinall
Mar 1, 2012·Personalized Medicine·Carsten Carlberg
Jul 1, 2012·Personalized Medicine·Joseph D McInerneyJoan A Scott
Mar 1, 2011·Personalized Medicine·Iain MillerAlain Huriez
May 1, 2011·Personalized Medicine·Purificação TavaresPeter Tolias

❮ Previous
Next ❯

Citations

Dec 4, 2016·Hematology·Saskia Middeldorp
Jun 7, 2014·Cytopathology : Official Journal of the British Society for Clinical Cytology·W D Mojica, R Bassey
Sep 21, 2021·International Journal of Radiation Oncology, Biology, Physics·Kundan ThindSarah Quirk

❮ Previous
Next ❯

Methods Mentioned

BETA
chip
genotyping

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.